Difficulty: Medium
Average Score: 73%
Practice
A 28-year-old woman secretary complains of fatigue that increases throughout the day. At the end of her workday, she says her eyes feel ├óÔé¼┼ôheavy├óÔé¼┬Ø and ├óÔé¼┼ôdroopy,├óÔé¼┬Ø although she does not feel particularly tired. Pyridostigmine is prescribed to treat her myasthenia gravis. How does pyridostigmine work?
Correct answer
A
Rationale
Pyridostigmine is an acetylcholinesterase inhibitor, so the correct answer is A) Blocks acetylcholine degradation. Acetylcholinesterase is an enzyme that breaks down acetylcholine in the synaptic cleft. By inhibiting this enzyme, pyridostigmine increases the levels of acetylcholine available for binding to postsynaptic receptors, thus improving muscle strength in conditions like myasthenia gravis.
Option B) Blocks dopamine degradation is incorrect as pyridostigmine does not affect dopamine levels. Option C) Stimulates acetylcholine release is incorrect because pyridostigmine works by preventing acetylcholine breakdown, not by stimulating its release. Option D) Stimulates muscarinic cholinergic receptors is incorrect as pyridostigmine does not directly stimulate receptors but rather indirectly enhances acetylcholine activity.
In an educational context, understanding how pyridostigmine works is crucial for healthcare professionals managing patients with myasthenia gravis. It highlights the importance of acetylcholine in neuromuscular transmission and the role of acetylcholinesterase inhibitors in treating conditions characterized by decreased muscle strength due to impaired neuromuscular transmission.
Option B) Blocks dopamine degradation is incorrect as pyridostigmine does not affect dopamine levels. Option C) Stimulates acetylcholine release is incorrect because pyridostigmine works by preventing acetylcholine breakdown, not by stimulating its release. Option D) Stimulates muscarinic cholinergic receptors is incorrect as pyridostigmine does not directly stimulate receptors but rather indirectly enhances acetylcholine activity.
In an educational context, understanding how pyridostigmine works is crucial for healthcare professionals managing patients with myasthenia gravis. It highlights the importance of acetylcholine in neuromuscular transmission and the role of acetylcholinesterase inhibitors in treating conditions characterized by decreased muscle strength due to impaired neuromuscular transmission.